PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Introduces HTS-Optimized EnzoLyte™ Caspase Assay Kits - Apoptosis, a programmed, cell-autonomous death process, plays important roles in a variety of physiological and pathological events1.
AnaSpec Introduces HTS-Optimized EnzoLyte™ Caspase Assay Kits

 

NewswireToday - /newswire/ - San Jose, CA, United States, 2006/09/12 - Apoptosis, a programmed, cell-autonomous death process, plays important roles in a variety of physiological and pathological events1..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

These range from normal fetal development to diseases, such as cancer2, organ failure and neurodegenerative diseases. During apoptosis, caspases execute the disassembly of cellular components by proteolytic cleavage of a variety of substrates, such as poly-(ADP ribose) polymerase3, DNA-dependent protein kinase (DNA-PK), topoisomerases, and protein kinase C delta4. At least ten caspases have been discovered. Some of these caspases identify and cleave a specific peptide substrate, while others recognize the same peptide substrate4.

AnaSpec’s line of EnzoLyte™ Caspase Assay Kits are optimized for high-throughput screening. HTS-optimized features include: one-step homogeneous assays, a convenient mix-and-read format, and highly sensitive fluorimetric components.

EnzoLyte™ Homogeneous Caspase-3/7 Assay Kits
- For detecting caspase 3/7 activity in cells and/or for screening caspase 3/7 inducers or inhibitors
- Measures activity directly in 96- or 384-well microplate, bifunctional lysis buffer lyses cells as well as provides optimal buffer condition for caspase 3/7 activity

EnzoLyte™ Homogeneous AFC Caspase-3/7 Assay Kit
· 500 assays in 96-well format
· Ex/Em(nm)=370/500

EnzoLyte™ Homogeneous AMC Caspase-3/7 Assay Kit
· 500 assays in 96-well format
· Ex/Em(nm)=340/440

EnzoLyte™ Homogeneous Rh110 Caspase-3/7 Assay Kit
· 500 assays in 96-well format
· Ex/Em(nm)=501/527

EnzoLyte™ Caspase Profiling Kits
- For assaying caspase protease activities

EnzoLyte™ AMC Caspase Profiling Kit
· 8 AMC-based substrates coated to two 96-well plates, AMC fluorescence reference std coated on the same plate
· Ex/Em=340/440 nm
EnzoLyte™ AFC Caspase Profiling Kit
· 8 AFC-based substrates coated to two 96-well plates, AFC fluorescence reference std coated on same plate
· Ex/Em=370/500 nm
EnzoLyte™ Caspase Substrate Sampler Kits
- The best solution for identifying a suitable substrate for designing AFC-based caspase assays

EnzoLyte™ AMC Caspase Substrate Sampler Kit
· 8 AMC-based substrates in individual vials. Each substrate contains ample amount for 100 assays in a 96-well format
· Ex/Em=340/440 nm
EnzoLyte™ AFC Caspase Substrate Sampler Kit
· 8 AFC-based substrates in individual vials. Each substrate contains ample amount for 100 assays in a 96-well format
· Ex/Em=370/500 nm

References
1. Thornberry, NA. and Y. Lazebnik, Science 281, 1312-1316 (1998).
2. Reed, JC. J. Clin. Oncol. 17, 2941-2953 (1999).
3. Lazebnik, YA. et al. Nature 371, 346-347 (1994).
4. Villa, P. et al. Trends Biochem. Sci. 22, 388-393 (1997).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces HTS-Optimized EnzoLyte™ Caspase Assay Kits

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Debra Thai 
800-452-5530 marketing[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)